Fresenius Medical Care AG & Co. KGaA FMS
$ 22.18
0.91%
Annual report 2023
added 11-16-2024
Fresenius Medical Care AG & Co. KGaA Balance Sheet 2011-2024 | FMS
Annual Balance Sheet Fresenius Medical Care AG & Co. KGaA
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | 5.72 B | 6.07 B | 2.9 B | 5.71 B | 6.87 B | 7.31 B | 7.21 B | 5.6 B | 5.67 B | 5.21 B | ||
Long Term Debt |
- | - | - | 6.8 B | 6.46 B | 5.05 B | 5.79 B | 6.85 B | 7.18 B | 7.47 B | 5.61 B | 5.93 B | 4.24 B |
Long Term Debt Current |
- | - | - | - | 622 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 13.1 B | 13.2 B | - | 7.07 B | 7.9 B | 9.93 B | 9.93 B | 9.82 B | 7.3 B | 7.52 B | 5.56 B |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
19.1 B | 20.3 B | 20.4 B | 19.4 B | 19.7 B | 13.3 B | 13.2 B | 14.7 B | 13.8 B | 12.7 B | 9.87 B | 9.92 B | 8.85 B |
Deferred Revenue |
- | - | - | 606 M | 1.85 B | - | 275 M | - | - | - | - | - | - |
Retained Earnings |
- | - | 10.8 B | 10.3 B | 9.45 B | 8.83 B | 7.14 B | 8.4 B | 7.2 B | 5.84 B | 4.62 B | 4.21 B | 3.59 B |
Total Assets |
33.9 B | 35.8 B | 34.4 B | 31.7 B | 32.9 B | 26.2 B | 24 B | 25.6 B | 23.4 B | 20.9 B | 16.7 B | 16.9 B | 15.1 B |
Cash and Cash Equivalents |
1.4 B | 1.27 B | 1.48 B | 1.08 B | 1.01 B | 2.15 B | 978 M | 709 M | - | - | - | - | - |
Book Value |
14.8 B | 15.4 B | 14 B | 12.3 B | 13.2 B | 12.9 B | 10.8 B | 10.9 B | 9.6 B | 8.25 B | 6.87 B | 6.96 B | 6.22 B |
Total Shareholders Equity |
- | - | 14 B | 12.3 B | 13.2 B | 12.9 B | 10.8 B | 11.1 B | 9.81 B | - | - | - | - |
All numbers in EUR currency
Quarterly Balance Sheet Fresenius Medical Care AG & Co. KGaA
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | 3.88 B | 4.04 B | 4.03 B | 3.96 B | 3.94 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 13.8 B | 13.1 B | 12.9 B | 12.8 B | 12.7 B | 13.3 B | 13.4 B | 12.8 B | 12.2 B | 12.6 B | 12.2 B | 11.9 B | 11.8 B | 7.07 B | 7.19 B | 7.57 B | 7.82 B | 7.9 B | - | - | - | 9.15 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 20.2 B | 20.4 B | 20.4 B | 20.2 B | 20 B | 19.4 B | 20.4 B | 20.9 B | 20.8 B | 19.7 B | 19.6 B | 19.2 B | 19.1 B | 13.3 B | 13.2 B | 13.1 B | 13.2 B | 13.2 B | - | - | - | 14.5 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | 11 B | 10.8 B | 10.6 B | 10.3 B | 10.5 B | 10.3 B | 10.1 B | 10.1 B | 9.73 B | 9.45 B | 9.21 B | 8.86 B | 8.99 B | 8.83 B | 8.41 B | 8.15 B | 7.48 B | 7.14 B | - | - | - | 6.09 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | 34.7 B | 34.4 B | 33.8 B | 33 B | 33.2 B | 31.7 B | 33 B | 34.2 B | 34.1 B | 32.9 B | 33.2 B | 32 B | 32.4 B | 26.2 B | 25.6 B | 25 B | 24.2 B | 24 B | 24.3 B | 24.7 B | 25.8 B | 25.5 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 1.17 B | 1.48 B | 1.56 B | 1.41 B | 1.07 B | 1.08 B | 1.6 B | 1.89 B | 1.05 B | 1.01 B | 965 M | 922 M | 959 M | 2.15 B | 1.75 B | 1.66 B | 1.66 B | 978 M | 729 M | 721 M | 671 M | 709 M | - | - | - | 505 M | - | - | - | 522 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | 14.5 B | 14 B | 13.4 B | 12.8 B | 13.2 B | 12.3 B | 12.7 B | 13.3 B | 13.3 B | 13.2 B | 13.5 B | 12.8 B | 13.2 B | 12.9 B | 12.3 B | 12 B | 10.9 B | 10.8 B | 24.3 B | 24.7 B | 25.8 B | 11.1 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 14.5 B | 14 B | 13.4 B | 12.8 B | 13.2 B | 12.3 B | 12.7 B | 13.3 B | 13.3 B | 13.2 B | 13.5 B | 12.8 B | 13.2 B | 12.9 B | 12.3 B | 12 B | 12 B | 10.8 B | 10.7 B | 10.7 B | 10.7 B | 11.1 B | - | - | - | 9.81 B | - | - | - | 8.39 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency